Cited by 1,107Nanoparticle-Based Drug DeliveryBarrier Structure and Function StudiesDrug Transport and Resistance Mechanisms

The DOI matches its Crossref record; 47 of the 50 references it cites were found in a registry or an index.

Nanoparticulate systems for brain delivery of drugs.

Kreuter, Jörg·2001·Advanced Drug Delivery Reviews

DOI 10.1016/s0169-409x(00)00122-8

Open this paper in CoChat — free account

Abstract

The blood--brain barrier (BBB) represents an insurmountable obstacle for a large number of drugs, including antibiotics, antineoplastic agents, and a variety of central nervous system (CNS)-active drugs, especially neuropeptides. One of the possibilities to overcome this barrier is a drug delivery to the brain using nanoparticles. Drugs that have successfully been transported into the brain using this carrier include the hexapeptide dalargin, the dipeptide kytorphin, loperamide, tubocurarine, the NMDA receptor antagonist MRZ 2/576, and doxorubicin. The nanoparticles may be especially helpful for the treatment of the disseminated and very aggressive brain tumors. Intravenously injected doxorubicin-loaded polysorbate 80-coated nanoparticles were able to lead to a 40% cure in rats with intracranially transplanted glioblastomas 101/8. The mechanism of the nanoparticle-mediated transport of the drugs across the blood-brain barrier at present is not fully elucidated. The most likely mechanism is endocytosis by the endothelial cells lining the brain blood capillaries. Nanoparticle-mediated drug transport to the brain depends on the overcoating of the particles with polysorbates, especially polysorbate 80. Overcoating with these materials seems to lead to the adsorption of apolipoprotein E from blood plasma onto the nanoparticle surface. The particles then seem to mimic low density lipoprotein (LDL) particles and could interact with the LDL receptor leading to their uptake by the endothelial cells. After this the drug may be released in these cells and diffuse into the brain interior or the particles may be transcytosed. Other processes such as tight junction modulation or P-glycoprotein (Pgp) inhibition also may occur. Moreover, these mechanisms may run in parallel or may be cooperative thus enabling a drug delivery to the brain.

Integrity signals

Registry

Crossref · 10.1016/s0169-409x(00)00122-8

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.
Cordon‐Cardo, C., O’Brien, J. P., Casals, D., Rittmann-Grauer, L., Biedler, J. L., Melamed, M. R., & Bertino, J. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.695 · Cited by 1,750
Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins
Pitas, R. E., Boyles, J. K., Lee, S. H., Foss, D., & Mahley, R. W. (1987) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(87)90295-5 · Cited by 693
Brain drug delivery of small molecules using immunoliposomes
Huwyler, J., Wu, D., & Pardridge, W. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14164 · Cited by 660
An Easier, Reproducible, and Mass‐Production Method to Study the Blood–Brain Barrier In Vitro
Dehouck, M., Méresse, S., Delorme, P., Fruchart, J., & Cecchelli, R. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb01236.x · Cited by 548
Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)
Kreuter, J., Alyautdin, R. N., Kharkevich, D. A., & Aa, I. (1995) · Brain Research · doi:10.1016/0006-8993(95)00023-j · Cited by 538
Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles
Gulyaev, A. E., Gelperina, S. E., Skidan, I. N., Antropov, A. S., Kivman, G. Y., & Kreuter, J. (1999) · Pharmaceutical Research · doi:10.1023/a:1018983904537 · Cited by 521
A New Function for the LDL Receptor: Transcytosis of LDL across the Blood–Brain Barrier
Dehouck, B., Fenart, L., Dehouck, M.-P., Pierce, A., Torpier, G., & Cecchelli, R. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.138.4.877 · Cited by 490
Hyperalgesia Induced by Naloxone Follows Diurnal Rhythm in Responsivity to Painful Stimuli
Frederickson, R. C. A., Burgis, V., & Edwards, J. D. (1977) · Science · doi:10.1126/science.561998 · Cited by 379
Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo.
Pardridge, W. M., Buciak, J. L., & Friden, P. M. (1991) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20567-5 · Cited by 358
Delivery of Loperamide Across the Blood-Brain Barrier with Polysorbate 80-Coated Polybutylcyanoacrylate Nanoparticles
Alyautdin, R. N., Petrov, V. E., Langer, K., Berthold, A., Kharkevich, D. A., & Kreuter, J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012098005098 · Cited by 352

Show all 50 references

Research works printed but not linked: 6

Kreuter, 1994, Nanoparticles, Vol. 10, 165
Alyautdin, 1995, Analgesic activity of the hexapeptide dalargin adsorbed on the surface of polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles, Eur. J. Pharm. Biopharm., 41, 44
Ramge, 2000, Polysorbate 80-coating enhances uptake of polybutylcyanoacrylate (PBCA)-nanoparticles by human, bovine and murine primary brain capilary endothelial cells, Eur. J. Neuro., 12, 1935
Steiniger, 1999, The influence of polysorbate 80-coated nanoparticles on bovine brain capillary endothelial cells in vitro, Proc. Int. Symp. Control. Rel. Bioact. Mater., 26, 789
Fenart, 1999, Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood–brain barrier, J. Pharmacol. Exp. Ther., 291, 1017
Cecchelli, 1997, Receptor-mediated transcytosis of blood-borne molecules through blood–brain barrier endothelial cells: Drug targeting by endogenous transport routes, Proc. Intl. Symp. Control. Rel. Bioact. Mater., 24, 221

Sorted by citations

Items 401–500 of 1,000

Incorporation in polymeric nanocapsules improves the antioxidant effect of melatonin against lipid peroxidation in mice brain and liver
Schaffazick, S. R., Siqueira, I. R., Badejo, A. S., Jornada, D. S., Pohlmann, A. R., Netto, C. A., & Guterres, S. S. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.11.010 · Cited by 64
Physicochemical characterization andin vivobioluminescence imaging of nanostructured lipid carriers for targeting the brain: apomorphine as a model drug
Hsu, S.-H., Wen, C.-J., Al‐Suwayeh, S. A., Chang, H., Yen, T., & Fang, J. (2010) · Nanotechnology · doi:10.1088/0957-4484/21/40/405101 · Cited by 58
Apoferritin Nanocage for Brain Targeted Doxorubicin Delivery
Chen, Z., Zhai, M., Xie, X., Zhang, Y., Ma, S., Li, Z., Yu, F., Zhao, B., Zhang, M., Yang, Y., et al. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00341 · Cited by 58
Solid lipid nanoparticles for nose to brain delivery of donepezil: formulation, optimization by Box–Behnken design, in vitro and in vivo evaluation
Yasir, M., Sara, U. V. S., Chauhan, I., Gaur, P. K., Singh, A. P., Puri, D., & Ameeduzzafar (2017) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2017.1394872 · Cited by 59
Electron microscopic analysis of nanoparticles delivering thioflavin-T after intrahippocampal injection in mouse: implications for targeting β-amyloid in Alzheimer's disease
Härtig, W., Paulke, B., Varga, C., Seeger, J., Harkany, T., & Kacza, J. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(02)01399-x · Cited by 58
Potential of Lipid-Based Nanocarriers against Two Major Barriers to Drug Delivery—Skin and Blood–Brain Barrier
Khan, M. S., Mohapatra, S., Gupta, V., Ali, A., Naseef, P. P., Kuruniyan, M. S., Alshadidi, A. A. F., Alam, M. S., Mirza, M. A., & Iqbal, Z. (2023) · Membranes · doi:10.3390/membranes13030343 · Cited by 57
Cellular uptake mechanisms and intracellular distributions of polysorbate 80-modified poly (d,l-lactide-co-glycolide) nanospheres for gene delivery
Tahara, K., Yamamoto, H., & Kawashimà, Y. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.03.013 · Cited by 57
Effects of Copper-Loaded Chitosan Nanoparticles on Intestinal Microflora and Morphology in Weaned Piglets
Wang, M., Du, Y., Wang, C., Tao, W., He, Y., & Li, H. (2012) · Biological Trace Element Research · doi:10.1007/s12011-012-9410-0 · Cited by 57
Nanoparticulate devices for brain drug delivery
Celia, C., Cosco, D., Paolino, D., & Fresta, M. (2010) · Medicinal Research Reviews · doi:10.1002/med.20201 · Cited by 58
Polysorbate 80 coated poly (ɛ-caprolactone)–poly (ethylene glycol)–poly (ɛ-caprolactone) micelles for paclitaxel delivery
Wang, Y., Wang, C., Gong, C., Wang, Y., Guo, G. F., Luo, F., & Qian, Z. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.05.015 · Cited by 57
Zeolite Nanoparticles Inhibit Aβ–Fibrinogen Interaction and Formation of a Consequent Abnormal Structural Clot
Derakhshankhah, H., Hajipour, M. J., Barzegari, E., Lotfabadi, A., Ferdousi, M., Saboury, A. A., Ng, E., Raoufi, M., Awala, H., Mintova, S., et al. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b10941 · Cited by 57
The blood–brain barrier and beyond: Nano-based neuropharmacology and the role of extracellular matrix
Henrich‐Noack, P., Nikitovic, D., Neagu, M. T., Docea, A. O., Engin, A. B., Gelperina, S. E., Штильман, М. И., Mitsias, P. D., Tzanakakis, G. N., Gozes, I., et al. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.01.016 · Cited by 58
Drug delivery therapies I
Malafaya, P. B., Silva, G. A., Baran, E. T., & Reis, R. L. (2002) · Current Opinion in Solid State and Materials Science · doi:10.1016/s1359-0286(02)00075-x · Cited by 57
A bio-orthogonal functionalization strategy for site-specific coupling of antibodies on vesicle surfaces after self-assembly
Gai, M., Simon, J., Lieberwirth, I., Mailänder, V., Morsbach, S., & Landfester, K. (2019) · Polymer Chemistry · doi:10.1039/c9py01136f · Cited by 55
Self-assembled amphiphilic core-shell nanocarriers in line with the modern strategies for brain delivery
Elezaby, R. S., Gad, H. A., Metwally, A. A., Geneidi, A. S., & Awad, G. A. S. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.06.019 · Cited by 56
Nanomaterials for medical diagnosis and therapy
Kumar, C. S. S. R. (2007) · Cited by 56
Solid lipid nanoparticles: could they help to improve the efficacy of pharmacologic treatments for brain tumors?
Brioschi, A. M., Zenga, F., Zara, G. P., Gasco, M. R., Ducati, A., & Mauro, A. (2007) · Neurological Research · doi:10.1179/016164107x187017 · Cited by 56
Peptides: Important tools for the treatment of central nervous system disorders
Malavolta, L., & Cabral, F. R. (2011) · Neuropeptides · doi:10.1016/j.npep.2011.03.001 · Cited by 55
Reactivity of engineered inorganic nanoparticles and carbon nanostructures in biological media
Bastús, N. G., Casals, E., Vázquez‐Campos, S., & Puntes, V. (2008) · Nanotoxicology · doi:10.1080/17435390802217830 · Cited by 54
Oral delivery of lycopene-loaded microemulsion for brain-targeting: preparation, characterization, pharmacokinetic evaluation and tissue distribution
Guo, Y., Mao, X., Zhang, J., Sun, P. G., Wang, H., Zhang, Y., Ma, Y., Xu, S. H., Lv, R., & Liu, X. (2019) · Drug Delivery · doi:10.1080/10717544.2019.1689312 · Cited by 55
Enabling nanomaterial, nanofabrication and cellular technologies for nanoneuromedicines
Mallapragada, S. K., Brenza, T. M., McMillan, J., Narasimhan, B., Sakaguchi, D. S., Sharma, A. D., Zbarska, S., & Gendelman, H. E. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.12.013 · Cited by 55
Brain delivery of small interfering ribonucleic acid and drugs through intranasal administration with nano-sized polymer micelles
Kanazawa, T. (2015) · Medical Devices Evidence and Research · doi:10.2147/mder.s70856 · Cited by 54
Assessment of metabolites and AhR and CYP1A1 mRNA expression subsequent to prenatal exposure to inhaled benzo(a)pyrene
Wu, J., Ramesh, A., Nayyar, T., & Hood, D. B. (2003) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(03)00073-x · Cited by 56
Nanoemulsified green tea extract shows improved hypocholesterolemic effects in C57BL/6 mice
Kim, Y. J., Houng, S.-J., Kim, J. H., Kim, Y., Ji, H. G., & Lee, S. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.11.015 · Cited by 54
Synergistic enhancement effect of magnetic nanoparticles on anticancer drug accumulation in cancer cells
Zhang, R., Wang, X., Wu, C., Song, M., Li, J., Lv, G., Zhou, J. F., Chen, C., Dai, Y.-Y., Gao, F., et al. (2006) · Nanotechnology · doi:10.1088/0957-4484/17/14/043 · Cited by 54
Supramolecular devices to improve the treatment of brain diseases
Paolino, D., Cosco, D., Molinaro, R., Celia, C., & Fresta, M. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.02.006 · Cited by 53
Brain transport of neurotoxin‐I with PLA nanoparticles through intranasal administration in rats: a microdialysis study
Cheng, Q., Feng, J., Chen, J., Zhu, X., & Li, F. (2008) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.621 · Cited by 53
Development of novel bioadhesive granisetron hydrochloride spanlastic gel and insert for brain targeting and study their effects on rats
Abdelmonem, R., Nabarawi, M. E., & Attia, A. (2017) · Drug Delivery · doi:10.1080/10717544.2017.1413447 · Cited by 53
Glioma targeting peptide modified apoferritin nanocage
Zhai, M., Wang, Y., Zhang, L., Liang, M., Fu, S., Cui, L., Yang, M., Gong, W., Li, Z., Lian, Y., et al. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1464082 · Cited by 53
Mechanisms of the effectiveness of lipid nanoparticle formulations loaded with anti-tubercular drugs combinations toward overcoming drug bioavailability in tuberculosis
Banerjee, S., Roy, S., Bhaumik, K. N., & Pillai, J. D. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2019.1613409 · Cited by 53
Nanoparticles as Blood–Brain Barrier Permeable CNS Targeted Drug Delivery Systems
Grabrucker, A. M., Chhabra, R., Belletti, D., Forni, F., Vandelli, M. A., Ruozi, B., & Tosi, G. (2013) · Topics in Medicinal Chemistry · doi:10.1007/7355_2013_22 · Cited by 53
LDL receptors and their role in targeted therapy for glioma: a review
Pawar, S., Koneru, T., McCord, E., Tatiparti, K., Sau, S., & Iyer, A. K. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.02.008 · Cited by 56
Development of glutathione-conjugated asiatic acid-loaded bovine serum albumin nanoparticles for brain-targeted drug delivery
Raval, N. J., Mistry, T., Acharya, N. S., & Acharya, S. R. (2015) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12460 · Cited by 52
Methodologies to Assess Drug Permeation Through the Blood–Brain Barrier for Pharmaceutical Research
Passeleu, C. L. B., Carrupt, P., Scherrmann, J. M. G., & Martel, S. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1119-z · Cited by 55
Methylmethacrylate–sulfopropylmethacrylate nanoparticles with surface RMP-7 for targeting delivery of antiretroviral drugs across the blood–brain barrier
Kuo, Y., & Lee, C.-L. (2011) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2011.09.048 · Cited by 52
Design and evaluation of lipoprotein resembling curcumin-encapsulated protein-free nanostructured lipid carrier for brain targeting
Meng, F., Asghar, S., Xu, Y., Wang, J., Jin, X., Wang, Z., Wang, J., Ping, Q. N., Zhou, J., & Xiao, Y. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.04.033 · Cited by 52
The influence of surface charge on serum protein interaction and cellular uptake: studies with dendritic polyglycerols and dendritic polyglycerol-coated gold nanoparticles
Bewersdorff, T., Vonnemann, J., Kanik, A., Haag, R., & Haase, A. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s124295 · Cited by 52
Synthesis, Characterization, and Cytotoxicity of Iron Oxide Nanoparticles
Kanagesan, S., Hashim, M., Tamilselvan, S., Alitheen, N. B., Ismail, I., Hajalilou, A., & Ahsanul, K. (2013) · Advances in Materials Science and Engineering · doi:10.1155/2013/710432 · Cited by 53
Targeted brain delivery of itraconazole via RVG29 anchored nanoparticles
Chen, W., Zhan, C., Gu, B., Meng, Q., Wang, H., Lu, W., & Hou, H. (2010) · Journal of drug targeting · doi:10.3109/1061186x.2010.492523 · Cited by 52
Niosomes of Ascorbic Acid and α-Tocopherol in the Cerebral Ischemia-Reperfusion Model in Male Rats
Varshosaz, J., Taymouri, S., Pardakhty, A., Asadi‐Shekaari, M., & Babaee, A. (2014) · BioMed Research International · doi:10.1155/2014/816103 · Cited by 51
Enhanced Anticancer Potential of Encapsulated Solid Lipid Nanoparticles of TPD: A Novel Triterpenediol from Boswellia serrata
Bhushan, S., Kakkar, V., Pal, H. C., Guru, S. K., Kumar, A., Mondhe, D. M., Sharma, P. R., Taneja, S. C., Kaur, I. P., Singh, J., et al. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300385m · Cited by 51
Resveratrol Nanoparticles: A Promising Therapeutic Advancement over Native Resveratrol
Chung, I., Subramanian, U., Thirupathi, P., Venkidasamy, B., Samynathan, R., Gangadhar, B. H., Rajakumar, G., & Thiruvengadam, M. (2020) · Processes · doi:10.3390/pr8040458 · Cited by 53
Retraction notice to ‘‘Antiglioma activity of curcumin-loaded lipid nanoparticles and its enhanced bioavailability in brain tissue for effective glioblastoma therapy’’ [Acta Biomaterialia 8 (2012) 2670–2687]
Kundu, P., Mohanty, C., & Sahoo, S. K. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2012.03.048 · Cited by 51
Retracted
The applications of nanozymes in neurological diseases: From mechanism to design
Zhang, Y., Zhang, L., Wang, M., & Li, P. (2023) · Theranostics · doi:10.7150/thno.83370 · Cited by 50
Comparison of nanosuspensions and hydroxypropyl-β-cyclodextrin complex of melarsoprol: Pharmacokinetics and tissue distribution in mice
Zirar, S. B., Astier, A., Muchow, M., & Gibaud, S. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.05.012 · Cited by 50
Preparation and Evaluation of Carbamazepine Solid Lipid Nanoparticle for Alleviating Seizure Activity in Pentylenetetrazole-Kindled Mice
Qushawy, M. K. E., Prabahar, K., Abd-Alhaseeb, M., Swidan, S. A., & Nasr, A. M. (2019) · Molecules · doi:10.3390/molecules24213971 · Cited by 50
Understanding and circumventing the blood‐brain barrier
Begley, D. J. (2003) · Acta Paediatrica · doi:10.1111/j.1651-2227.2003.tb00226.x · Cited by 50
Toxins and derivatives in molecular pharmaceutics: Drug delivery and targeted therapy
Zhan, C., Li, C., Wei, X., Lu, W., & Lu, W. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.04.025 · Cited by 51
Protein-Functionalized PLGA Nanoparticles of Lamotrigine for Neuropathic Pain Management
Lalani, J., Patil, S., Kolate, A., Lalani, R., & Misra, A. R. (2014) · AAPS PharmSciTech · doi:10.1208/s12249-014-0235-3 · Cited by 50
Stem cell transplantation for neurometabolic and neurodegenerative diseases
Shihabuddin, L. S., & Aubert, I. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.12.015 · Cited by 49
In vivo evaluation of intracellular drug-nanocarriers infused into intracranial tumours by convection-enhanced delivery: distribution and radiosensitisation efficacy
Vinchon-Petit, S., Jarnet, D., Paillard, A., Benoît, J., Garcion, E., & Meneï, P. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-0012-4 · Cited by 49
On the Mechanism and Dynamics of Uptake and Permeation of Polyether-Copolyester Dendrimers Across an In Vitro Blood–Brain Barrier Model
Dhanikula, R. S., Hammady, T. M., & Hildgen, P. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21669 · Cited by 50
Drug Delivery to The Brain Using Polymeric Nanoparticles: A Review
Neha, B., Ganesh, B., & Kothiyal, P. (2013) · International Journal of Pharmaceutical and Life Sciences · doi:10.3329/ijpls.v2i3.15457 · Cited by 49
Transferrin-Coated Gadolinium Nanoparticles as MRI Contrast Agent
Korkusuz, H., Ulbrich, K., Welzel, K., Koeberle, V., Watcharin, W., Bahr, U., Chernikov, V. P., Knobloch, T., Petersen, S., Huebner, F., et al. (2012) · Molecular Imaging and Biology · doi:10.1007/s11307-012-0579-6 · Cited by 49
Uptake of apolipoprotein E fragment coupled liposomes by cultured brain microvessel endothelial cells and intact brain capillaries
Hülsermann, U., Hoffmann, M. M., Massing, U., & Fricker, G. (2009) · Journal of drug targeting · doi:10.1080/10611860903105986 · Cited by 51
Potential amyloid plaque-specific peptides for the diagnosis of Alzheimer's disease
Larbanoix, L., Burtéa, C., Laurent, S., LEUVEN, F. V., Toubeau, G., Elst, L. V., & Müller, R. N. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.09.021 · Cited by 49
Drug delivery’s quest for polymers: Where are the frontiers?
Merkle, H. P. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.04.038 · Cited by 49
Trans resveratrol loaded DSPE PEG 2000 coated liposomes: An evidence for prolonged systemic circulation and passive brain targeting
Vijayakumar, M. R., Kosuru, R., Vuddanda, P. R., Singh, S. K., & Singh, S. (2016) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2016.02.009 · Cited by 49
The effect of surface treatment on the brain delivery of curcumin nanosuspension: in vitro and in vivo studies
Dibaei, M., Rouini, M. R., Sheikholeslami, B., Gholami, M., & Dinarvand, R. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s199624 · Cited by 51
Cellular Uptake Behavior of Unfunctionalized and Functionalized PBCA Particles Prepared in a Miniemulsion
Weiss, C. K., Lorenz, M. R., Landfester, K., & Mailänder, V. (2007) · Macromolecular Bioscience · doi:10.1002/mabi.200700046 · Cited by 49
Nanotherapeutics for Alzheimer’s disease (AD): Past, present and future
Fazil, M., Shadab, Baboota, S., Sahni, J. K., & Ali, J. (2011) · Journal of drug targeting · doi:10.3109/1061186x.2011.607499 · Cited by 47
Non-invasive systemic drug delivery through mucosal routes
Goyal, A. K., Singh, R., Chauhan, G., & Rath, G. (2018) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1463230 · Cited by 48
Ambient air pollution and brain cancer mortality
McKean‐Cowdin, R., Calle, E. E., Peters, J. M., Henley, S. J., Hannan, L. M., Thurston, G. D., Thun, M. J., & Preston‐Martin, S. (2009) · Cancer Causes & Control · doi:10.1007/s10552-009-9412-1 · Cited by 49
Targeting brain cells with glutathione-modulated nanoliposomes: in vitro and in vivo study
Salem, F., Ahammed, S. M., Hassaballah, A. S., & Omar, M. M. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s85302 · Cited by 47
Nanocrystals: Production, Cellular Drug Delivery, Current and Future Products
Müller, R. H., Shegokar, R., Gohla, S., & Keck, C. M. (2011) · Fundamental biomedical technologies · doi:10.1007/978-94-007-1248-5_15 · Cited by 47
Intravenous tolerance of a nanoparticle-based formulation of doxorubicin in healthy rats
Переверзева, Э. Р., Трещалин, И. Д., Бодягин, Д. А., Максименко, О. О., Kreuter, J., & Gelperina, S. E. (2008) · Toxicology Letters · doi:10.1016/j.toxlet.2008.01.020 · Cited by 47
The formulation of polyhedral boranes for the boron neutron capture therapy of cancer
Calabrese, G., Nesnas, J., Barbu, E., Fatouros, D. G., & Tsibouklis, J. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.09.014 · Cited by 46
Future prospects of nanoparticles on brain targeted drug delivery
Chakraborty, C., Sarkar, B., Hsu, C. H., Wen, Z., Lin, C. S., & Shieh, P.-C. (2008) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9759-2 · Cited by 46
Binding fullerenol C60(OH)24 to dsDNA
Ungurenasu, C., Pinteala, & Dascalu (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s6630 · Cited by 46
Nanocarriers for Tracking and Treating Diseases
Marrache, S., Pathak, R., Darley, K., Choi, J. J., Zaver, D., Kolishetti, N., & Dhar, S. (2013) · Current Medicinal Chemistry · doi:10.2174/0929867311320280007 · Cited by 46
Nanomedicines for oral administration based on diverse nanoplatform
Sim, T., Lim, C., Hoang, N. H., Joo, H., Lee, J., Kim, D.-W., Lee, E. S., Youn, Y. S., Kim, J. O., & Oh, K. T. (2016) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-016-0255-y · Cited by 46
Calcium phosphate-based nanosystems for advanced targeted nanomedicine
Esposti, L. D., Carella, F., Adamiano, A., Tampieri, A., & Iafisco, M. (2018) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2018.1451879 · Cited by 47
Development of Engineered Nanoparticles Expediting Diagnostic and Therapeutic Applications Across Blood–Brain Barrier
Sardoiwala, M. N., Kaundal, B., & Choudhury, S. R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813351-4.00038-9 · Cited by 49
Revolutionary Impact of Nanodrug Delivery on Neuroscience
Khanbabaie, R., & Jahanshahi, M. (2012) · Current Neuropharmacology · doi:10.2174/157015912804499456 · Cited by 47
Distribution of nobiletin chitosan-based microemulsions in brain following i.v. injection in mice
Yao, J., Zhou, J., Ping, Q. N., Lu, Y., & Chen, L. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.10.010 · Cited by 46
Targeting the Brain – Surmounting or Bypassing the Blood–Brain Barrier
Potschka, H. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-00477-3_14 · Cited by 47
Preparation and characterization of polysaccharide-based nanoparticles with anticoagulant activity
da Silva, L. C., Garcia, T., Mori, M., Sandri, G., Bonferoni, M., Finotelli, P., Cinelli, L. P., Caramella, C., & Cabral, L. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s31632 · Cited by 39
Manganese-containing Prussian blue nanoparticles for imaging of pediatric brain tumors
Fernandes, R., Dumont, M., Yadavilli, S., Sze, R. W., & Nazarian, J. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s63472 · Cited by 46
Differential toxicological response to positively and negatively charged nanoparticles in the rat brain
Knudsen, K. B., Northeved, H., Ek, P. K., Permin, A., Andresen, T. L., Larsen, S., Wegener, K. M., Lam, H. R., & Lykkesfeldt, J. (2013) · Nanotoxicology · doi:10.3109/17435390.2013.829589 · Cited by 46
Transbuccal Delivery of CNS Therapeutic Nanoparticles: Synthesis, Characterization, and In Vitro Permeation Studies
Yuan, Q., Fu, Y., Kao, W. J., Janigro, D., & Yang, H. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn200078m · Cited by 45
Darunavir-Loaded Lipid Nanoparticles for Targeting to HIV Reservoirs
Desai, J. L., & Thakkar, H. P. (2017) · AAPS PharmSciTech · doi:10.1208/s12249-017-0876-0 · Cited by 45
Nanoformulations for Drug Delivery: Safety, Toxicity, and Efficacy
Lopalco, A., & Denora, N. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7899-1_17 · Cited by 45
Engineering Nanomaterials for Smart Drug Release
Singh, A. K., Yadav, T. P., Pandey, B., Gupta, V., & Singh, S. P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814029-1.00015-6 · Cited by 47
Core-shell type of nanoparticles composed of poly[(n-butyl cyanoacrylate)-co-(2-octyl cyanoacrylate)] copolymers for drug delivery application: Synthesis, characterization and in vitro degradation
Huang, C.-Y., & Lee, Y. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.06.008 · Cited by 45
Enhanced brain delivery of lamotrigine with Pluronic® P123-based nanocarrier
Wu, X., Liu, J., Shen, T. F., Wang, J., Zhou, J., Tang, X., Xu, L., & Hong, Z. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s62263 · Cited by 44
Brain delivery of transferrin coupled indinavir submicron lipid emulsions—Pharmacokinetics and tissue distribution
Kandadi, P., Afzal, S. M., Kumar, P. U., Ajumeera, R., & Veerabrahma, K. (2011) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2011.04.013 · Cited by 44
Emerging drugs for lysosomal storage diseases
Beck, M. (2010) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2010.498580 · Cited by 42
Proteins conjugated to poly(butyl cyanoacrylate) nanoparticles as potential neuroprotective agents
Reukov, V. V., Maximov, V. D., & Vertegel, A. A. (2010) · Biotechnology and Bioengineering · doi:10.1002/bit.22958 · Cited by 43
Intracellular tracking of protamine/antisense oligonucleotide nanoparticles and their inhibitory effect on HIV-1 transactivation
Dinauer, N., Lochmann, D., Demirhan, I., Bouazzaoui, A., Zimmer, A., Chandra, A., Kreuter, J., & von Briesen, H. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.02.020 · Cited by 43
Nanofibers Used for the Delivery of Analgesics
Tseng, Y., & Liu, S. (2015) · Nanomedicine · doi:10.2217/nnm.15.23 · Cited by 42
Revolutionary Impact of Nanodrug Delivery on Neuroscience
Khanbabaie, R., & Jahanshahi, M. (2012) · Current Neuropharmacology · doi:10.2174/157015912804143513 · Cited by 44
Targeted Drug Delivery Across the Blood Brain Barrier in Alzheimer’s Disease
Rocha, S. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990613 · Cited by 42
Biodegradable Nanoparticles for Delivery of Therapeutics in CNS Infection
DeMarino, C., Schwab, A., Pleet, M. L., Mathiesen, A. H., Friedman, J. M., El‐Hage, N., & Kashanchi, F. (2016) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-016-9692-7 · Cited by 42
Developmental therapeutics for patients with breast cancer and central nervous system metastasis: current landscape and future perspectives
Costa, R. L. B., Carneiro, B. A., Wainwright, D. A., Santa-Maria, C. A., Kumthekar, P., Chae, Y. K., Gradishar, W. J., Cristofanilli, M., & Giles, F. J. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw532 · Cited by 42
In vitro protein adsorption studies on nevirapine nanosuspensions for HIV/AIDS chemotherapy
Shegokar, R., Jansch, M., Singh, K. K., & Müller, R. H. (2010) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2010.10.012 · Cited by 42
Formulation, Optimization, in Vivo Pharmacokinetic, Behavioral and Biochemical Estimations of Minocycline Loaded Chitosan Nanoparticles for Enhanced Brain Uptake
Nagpal, K., Singh, S. K., & Mishra, D. N. (2013) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c12-00732 · Cited by 43
Nanoparticle Formulation Improves the Anticonvulsant Effect of Clonazepam on the Pentylenetetrazole-Induced Seizures: Behavior and Electroencephalogram
Leyva‐Gómez, G., González-Trujano, M. E., López-Ruiz, E., Couraud, P., Wekslerg, B., Romero, I. A., Miller, F., Delié, F., Allémann, É., & Quintanar‐Guerrero, D. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24044 · Cited by 41
Nanoparticles as contrast agents for brain nuclear magnetic resonance imaging in Alzheimer's disease diagnosis
Azria, D., Blanquer, S., Verdier, J., & Belamie, E. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb01599b · Cited by 43
Polysorbate-coated mesoporous silica nanoparticles as an efficient carrier for improved rivastigmine brain delivery
Basharzad, S. F., Hamidi, M., Maleki, A., Karami, Z., Mohamadpour, H., & Zanjani, M. R. S. (2022) · Brain Research · doi:10.1016/j.brainres.2022.147786 · Cited by 41
Hybrid Membrane-Derived Nanoparticles for Isoliquiritin Enhanced Glioma Therapy
Shi, W., Cao, X., Liu, Q., Zhu, Q., Liu, K., Deng, T., Yu, Q., Deng, W., Yu, J., Wang, Q., et al. (2022) · Pharmaceuticals · doi:10.3390/ph15091059 · Cited by 41

Authors: Kreuter, J.
Affiliations: Goethe University Frankfurt (DE)
Corresponding author: Kreuter, Jörg
Venue: Advanced Drug Delivery Reviews
Publisher: Elsevier BV
Published: 2001-03
Volume: 47
Issue: 1
Pages: 65-81
ISSN: 0169-409X (ISSN-L)
DOI: 10.1016/s0169-409x(00)00122-8
OpenAlex: W2072229818
Cited by: 1,107
References: 50
Citations by year: 2026: 15 · 2025: 20 · 2024: 26 · 2023: 39 · 2022: 32 · 2021: 43 · 2020: 47 · 2019: 40 · 2018: 47 · 2017: 53 · 2016: 63 · 2015: 57 · 2014: 55 · 2013: 65 · 2012: 76
FWCI: 1.84
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Advanced Drug Delivery Reviews (publishedVersion)
PubMed (publishedVersion)
Topics: Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords: blood-brain barrier, nanoparticle drug delivery, brain drug delivery, apolipoprotein E, glioblastoma, doxorubicin, neuropeptides, P-glycoprotein inhibition, tight junction modulation, transcytosis, central nervous system drugs
MeSH terms: Animals, Antineoplastic Agents, Blood-Brain Barrier, Brain, Brain Neoplasms, Capsules, Cells, Cultured, Doxorubicin, Drug Carriers, Endothelium, Vascular, Humans, Male, Polysorbates, Surface-Active Agents, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Nanoparticulate systems for brain delivery of drugs.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Citations

Cites

Cited by

Related

Metadata

Record

About these checks